Trial Profile
A multi-center, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of WelChol in combination with Zetia compared to Zetia alone in patients with primary hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary) ; Ezetimibe; Simvastatin
- Indications Hyperlipoproteinaemia type II
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Europe
- 10 Sep 2007 Status changed from in progress to completed.
- 05 Nov 2005 New trial record.